Table 3.
Baseline characteristics of BCPIE versus BCNIE in the prospective cohort
| BCPIE (n=37) | BCNIE (n=28) | P value | |
| Age (mean) | 39.75 | 38.2 | 0.64 |
| Male sex | 23 (63.9%) | 20 (71.4%) | 0.44 |
| Diabetes | 4 (11.1%) | 0 | |
| Hypertension | 5 (13.9%) | 5 (17.9%) | 0.68 |
| Current smokers | 7 (27%) | 17 (60.7%) | <0.01 |
| PLHIV | 9 (25.7%) | 9 (33.3%) | 0.49 |
| CD4 count cells/µL (mean) | 347 | 470 | 0.67 |
| c-ART | 6 (66.7%) | 7 (77.8%) | 0.65 |
| History of intravenous drug use | 5 (13.5%) | 0 | |
| History of valvular heart disease | 9 (25%) | 7 (25%) | 1 |
| Previous cardiac surgery | 7 (19.4%) | 3 (10.7%) | 0.35 |
| Antibiotic therapy prior to blood culture sampling | 7 (19.4%) | 10 (35.7%) | 0.15 |
| Surgery performed | 19 | 20 | 0.11 |
| In-hospital mortality | 5 (13.5%) | 4 (14.2%) | 0.95 |
BCNIE, blood culture negative infective endocarditis; BCPIE, blood culture positive infective endocarditis; c-ART, combination anti-retroviral therapy; PLHIV, people living with HIV.